Bacchus-F to please Dong-A

Published: 2011-08-19 06:58:00

Updated: 2011-08-19 06:58:00

With the possible reclassification of 48 over-the-counter (OTC) drugs as “quasi-drugs,” pharmaceutical companies, many of which saw their sales fall following a government crackdown on kickbacks given to doctors or pharmacies, expect a rebound, but only a few will gain an advantage, analysts clai...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK